VCAM1 and Hypertension: Yin and colleagues demonstrated that inhibiting VCAM-1 with a monoclonal antibody reduces monocyte adhesion and infiltration into the endothelium, thereby protecting against arterial hypertension and dysfunction caused by Ang-2 in a mouse model (79) (Figure 1F).